[PDF] Obstructive Sleep Apnea and Obesity: Implications for Public Health
with its comorbidities, especially with metabolic syndrome. One of the main components
contributing to sleep apnea is obesity; as well as diabetes mellitus type 2 (T2DM),
Obstructive Sleep Apnea Assessed by Overnight Polysomnography in Patients With Keratoconus.
keratoconus (KCN) and to evaluate the association between the severity of KCN and OSA.
OSA was diagnosed with an overnight home sleep apnea test. As estimated by home
Cardioventilatory Control in Preterm Born Children and the Risk of Obstructive Sleep Apnea
apnea (OSA) in preterm born children is unknown. Objectives To characterize phenotypes of
ventilatory control that are associated with the presence of OSA in preterm born children
Phenotyping Pharyngeal Pathophysiology Using Polysomnography in Patients with Obstructive Sleep Apnea
patient's own phenotypic causes ("traits") if a clinically-applicable approach were available.
Here we present a novel approach to quantify two key contributors to OSA—pharyngeal
[HTML] Different effects of apnea during rapid eye movement period on peripheral arterial stiffness in obstructive sleep apnea
stiffness was assessed by peripheral compliance index (CI) and central pulse wave velocity
derived from digital volume pulse (PWV DVP) by photoplethysmography. Overnight
A Pilot Study on the Biomechanical Assessment of Obstructive Sleep Apnea Pre and Post Bariatric Surgery
the severity of this risk can be reduced by bariatric surgery. This pilot study investigates the
perioperative effects of bariatric surgery on obstructive sleep apnea and on the physical and
Predicting response to oxygen therapy in obstructive sleep apnoea patients using a 10-minute daytime test
Type D Personality and Sleep Quality in Coronary Artery Disease Patients With and Without Obstructive Sleep Apnea: Mediating Effects of Anxiety and Depression
trait and sleep quality in coronary artery disease (CAD) patients with and without obstructive
sleep apnea (OSA) and to explore the mediating effects of anxiety and depression
FIBROTIC TISSUE STABILIZED BY CROSSLINKING FOR TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNEA
inducing agent to a subject following a stiffening procedure to the respiratory system. The
present invention has identified that such application or administration of a crosslinking
Neurological recovery after acute ischemic stroke with obstructive sleep apnea
of patients with an Anti-NMDAR encephalitis Previous article in issue: The HMGB1 is increased
in CSF of patients with an Anti-NMDAR encephalitis. View issue TOC Volume 137, Issue 2
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.